Trial document





This trial has been registered retrospectively.
drksid header

  DRKS00012649

Trial Description

start of 1:1-Block title

Title

Clinical characterization of lung adenocarcinoma

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

MLADC

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

http://--

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

Retrospectively various clinical parameters of patients are collected undergoing surgery for lung adenocarcinoma in our Hospital between 01/2009 and 05/2015.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

Retrospectively the clinical characterization of our prospectively collected cohort is done.

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00012649
  •   2017/08/18
  •   [---]*
  •   yes
  •   Approved
  •   623-15, Ethik-Kommission der Medizinischen Fakultät der Ludwig-Maximilians-Universität München
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   C34 -  Malignant neoplasm of bronchus and lung
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Clinical data from patients undergoing surgery for lung adenocarcinoma were retrospectively analyzed. Overall and disease-free survival was evaluated via phone calls.
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Non-interventional
  •   Observational study
  •   Single arm study
  •   Open (masking not used)
  •   [---]*
  •   Uncontrolled/Single arm
  •   Basic research/physiological study
  •   Single (group)
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Overall survival

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

Disease-free survival

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2016/01/30
  •   300
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   18   Years
  •   99   Years
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

surgery on loco-regional lung adenocarcinoma between 01/2009 and 05/2015

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

lack of surgery

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Asklepios Lungenfachklinik
    • Robert-Koch-Allee 2
    • 82131  Gauting
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    •   089/857910
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Asklepios Lungenfachklinik
    • Ms.  Dr. med.  Laura  Klotz 
    • Robert-Koch-Allee 2
    • 82131  Gauting
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Asklepios Lungenfachklinik
    • Ms.  Dr. med.   Laura  Klotz 
    • Robert-Koch-Allee 2
    • 82131  Gauting
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Asklepios Lungenfachklinik
    • Robert-Koch-Allee 2
    • 82131  Gauting
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    •   089/857910
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting complete, follow-up continuing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.